AstraZeneca Ends Phase 3 Lung Cancer Drug Trial After Review WSJAstraZeneca suffers another setback as it halts volrustomig lung cancer trial ReutersAstraZeneca cans late-stage bispecific trial after lung cancer setback Endpoints News
Akeso and Summit’s lung cancer drug shows worsening tumor-progression benefit STAT
Drug that targets an inflammatory enzyme could help prevent lung cancer MIT News
Summit, Akeso’s China approval celebration cut short as survival benefit degrades BioSpace
AstraZeneca touts Enhertu, Orpathys dual lung cancer wins amid bispecific failure Fierce Pharma
Dad with Stage 4 Lung Cancer Pushed in Chair by His Sons to Complete 5K Race People.com
Obesity weakens anti-tumor immune response in lung cancer, but exercise may restore it Medical Xpress
Lung cancer can stay silent for years: Who should get screened and why early detection matters The Times of India
Cigars, Pipes Up Lung Cancer Risk, Raise Screening Needs Medscape
New $60 Blood Test Detects Lung Cancer Without Costly DNA Sequencing SciTechDaily
Update on eVOLVE-Lung02 Phase III trial of volrustomig plus chemotherapy in metastatic non-small cell lung cancer AstraZeneca
Caspase-1 Inhibition Points to a Possible Lung Cancer Interception Strategy Inside Precision Medicine
AstraZeneca scraps Phase 3 trial of new bispecific in lung cancer BioPharma Dive
Obesity Weakens Anti-Tumor Immune Response in Lung Cancer – But Exercise May Restore It Roswell Park Comprehensive Cancer Center
Enhertu Delayed Cancer Growth as a First Treatment for HER2-Mutant Lung Cancer Cure Today
AstraZeneca pulls plug on late-stage lung cancer trial, extending losing streak BioSpace
Multi-source data-driven machine learning improves lung cancer care News-Medical
Research regarding advanced lung cancer patients and treatment South Carolina Public Radio
Storm damages home of Louisville woman with lung cancer WHAS11
AstraZeneca abandons lung cancer treatment trial in fresh setback for drugs giant Yahoo Finance UK
AstraZeneca suffers another setback as it halts volrustomig lung cancer trial WTVB
When Cancer Diagnoses Lead to Guilt Cure Today
LUCAS to offer lung cancer screening in Gilbert and Martinsburg WV News
eVOLVE-Lung02 Trial of Volrustomig Discontinued in Metastatic NSCLC CancerNetwork
AstraZeneca’s Lung Cancer Bet Hits a Dead End Yahoo Finance
AstraZeneca touts separate late-stage lung cancer wins with Tagrisso, Enhertu Endpoints News
Tagrisso, Orpathys combo leads dual success for AstraZeneca in lung cancer trials FirstWord Pharma
How new tech is changing lung nodule care American Medical Association | AMA
AstraZeneca suffers blow as pivotal lung cancer study of volrustomig halted FirstWord Pharma
Pharmalittle: We're reading about an AstraZeneca setback, falling U.S. drug prices, and more STAT
How Tarlatamab Compares With CNS-Directed Chemo/Radiation in SCLC CancerNetwork
When a Mother and Wife Gets Cancer Cure Today
Savolitinib Plus Osimertinib Improves PFS, OS in MET-Driven NSCLC Targeted Oncology
Breaking News: A New Era for Lung Cancer Treatment – Akeso Biopharma Oncodaily
Small cell lung cancer research gets a boost Fred Hutchinson Cancer Center
UK Shares Start Week Downbeat; AstraZeneca Shares Data from Lung Cancer Trials Yahoo Finance UK
Hutchmed shares rise 5% after positive Phase III lung cancer trial results Investing.com
Survival win for Tagrisso-Orpathys combo in resistant lung cancer The Pharma Letter
TAGRISSO® (osimertinib) plus savolitinib demonstrated statistically significant and clinically meaningful improvements in progression-free and overall survival in MET-driven EGFR-mutated lung cancer after progression on TAGRISSO Business Wire
AstraZeneca Halts Lung Cancer Trial for Volrustomig; Reports Positive Data for Tagrisso Combo, Enhertu Yahoo Finance UK